Journal article · 2023 · Open access
Biomarker Discovery in Neurodegenerative Disorders
Excerpta Medica Archives Journal: Transaction A · Published 15 February 2023 · DOI 10.5281/zenodo.19613195
In brief
“Biomarker Discovery in Neurodegenerative Disorders” is a 2023 journal article by Noah Dubois and 2 co-authors, published in Excerpta Medica Archives Journal: Transaction A. OpenAlex counts 0 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Excerpta Medica Archives Journal: Transaction A.
- Citations
- 0
- References
- 18
- Authors
- 3
Abstract
Neurodegenerative disorders -- Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS),and frontotemporal dementia (FTD) -- collectively affect over 55 million people worldwide, yet diagnosis typically occursyears after irreversible neuronal loss has begun, and no disease-modifying therapy has demonstrated unequivocalclinical benefit partly because trials enrol patients too late in the disease course. Blood-based biomarkers that can detectneurodegeneration before clinical symptoms emerge would transform both diagnosis and clinical trial design. Weevaluated five biomarker discovery frameworks -- cerebrospinal fluid (CSF) proteomics, plasma neurofilament andphospho-tau assays, multi-omic blood profiling, neuroimaging-derived digital biomarkers, and ML-integrated multi-modalpanels -- across four neurodegenerative diseases in a prospective cohort of 4,286 participants (1,842 AD, 1,124 PD, 648ALS, 672 FTD) from five European memory and movement disorder clinics (Vienna, Madrid, Berlin, Amsterdam, andLondon) followed for a median of 4.2 years (2016-2022). Our Neurodegenerative Biomarker Utility Score (NBUS)integrates diagnostic accuracy, preclinical detection capability, disease progression tracking, treatment responsesensitivity, and clinical accessibility. ML-integrated multi-modal panels achieved the highest NBUS (0.928), detectingpreclinical AD 6.4 years before symptom onset (AUROC 0.92) by combining plasma p-tau217, GFAP, NfL, and amyloidPET features. Plasma biomarkers alone (NBUS 0.904) achieved AUROC 0.90 for AD diagnosis -- approaching CSFperformance while requiring only a blood draw.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Dubois, N., Novak, O., & Schmidt, M. (2023). Biomarker Discovery in Neurodegenerative Disorders. Excerpta Medica Archives Journal: Transaction A. https://doi.org/10.5281/zenodo.19613195
MLA 9
Dubois, Noah, et al. “Biomarker Discovery in Neurodegenerative Disorders.” Excerpta Medica Archives Journal: Transaction A, 2023. https://doi.org/10.5281/zenodo.19613195.
Chicago
Dubois, Noah, Oscar Novak, and Matteo Schmidt. 2023. “Biomarker Discovery in Neurodegenerative Disorders.” Excerpta Medica Archives Journal: Transaction A. https://doi.org/10.5281/zenodo.19613195.
Harvard
Dubois, N., Novak, O. and Schmidt, M. (2023) ‘Biomarker Discovery in Neurodegenerative Disorders’, Excerpta Medica Archives Journal: Transaction A. doi:10.5281/zenodo.19613195.
IEEE
N. Dubois, O. Novak, and M. Schmidt, “Biomarker Discovery in Neurodegenerative Disorders,” Excerpta Medica Archives Journal: Transaction A, 2023, doi: 10.5281/zenodo.19613195.
BibTeX
@article{dubois2023biomarker,
title = {{Biomarker Discovery in Neurodegenerative Disorders}},
author = {Dubois, Noah and Novak, Oscar and Schmidt, Matteo},
journal = {Excerpta Medica Archives Journal: Transaction A},
year = {2023},
doi = {10.5281/zenodo.19613195},
url = {https://doi.org/10.5281/zenodo.19613195}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- neurodegenerative diseases
- blood-based biomarkers
- preclinical Alzheimer's disease
- Parkinson's disease
- amyotrophic lateral sclerosis
- frontotemporal dementia
- cerebrospinal fluid proteomics
- plasma neurofilament light chain
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Dubois, N., Novak, O., & Schmidt, M. (2023). Biomarker Discovery in Neurodegenerative Disorders. Excerpta Medica Archives Journal: Transaction A. https://doi.org/10.5281/zenodo.19613195
How many times has this paper been cited?
0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Excerpta Medica Archives Journal: Transaction A: sign in and open the PDF from this page.
Who wrote this paper?
Noah Dubois, Oscar Novak, Matteo Schmidt.
What is the DOI of this paper?
10.5281/zenodo.19613195, permanently at https://doi.org/10.5281/zenodo.19613195. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.